Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Adami

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
BMC Cancer|October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell deathFrancesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Circulation|April 6, 2016
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance PatternManuel De Lazzari, Marny Fedrigo, Federico Migliore, et al.
British Journal of Haematology|August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activityLivio Trentin, Marta Miorin, Monica Facco, et al.
Journal of Neuroimmunology|December 3, 2014
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal studyChiara Briani, Chiara Dalla Torre, Federica Lessi, et al.
American Journal of Hematology|November 17, 2011
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemiaGiuseppe Todeschini, Massimiliano Bonifacio, Cristina Tecchio, et al.
Blood|May 11, 2006
Multiple myeloma cell survival relies on high activity of protein kinase CK2Francesco A Piazza, Maria Ruzzene, Carmela Gurrieri, et al.
Blood Cancer Journal|February 15, 2018
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myelomaSara Canovas Nunes, Martina Manzoni, Marco Pizzi, et al.
Journal of Hematology & Oncology|November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicityLaura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 18, 2011
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignanciesAlessandra Galioto, Filippo Morando, Silvia Rosi, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
BMC Cancer|October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell deathFrancesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Circulation|April 6, 2016
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance PatternManuel De Lazzari, Marny Fedrigo, Federico Migliore, et al.
British Journal of Haematology|August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activityLivio Trentin, Marta Miorin, Monica Facco, et al.
Journal of Neuroimmunology|December 3, 2014
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal studyChiara Briani, Chiara Dalla Torre, Federica Lessi, et al.
American Journal of Hematology|November 17, 2011
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemiaGiuseppe Todeschini, Massimiliano Bonifacio, Cristina Tecchio, et al.
Blood|May 11, 2006
Multiple myeloma cell survival relies on high activity of protein kinase CK2Francesco A Piazza, Maria Ruzzene, Carmela Gurrieri, et al.
Blood Cancer Journal|February 15, 2018
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myelomaSara Canovas Nunes, Martina Manzoni, Marco Pizzi, et al.
Journal of Hematology & Oncology|November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicityLaura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 18, 2011
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignanciesAlessandra Galioto, Filippo Morando, Silvia Rosi, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
Pageof 5